| Identification | Back Directory | [Name]
6H-Purin-6-one, 2-[[(3,4-dichlorophenyl)methyl]amino]-1,7-dihydro-7-[2-(4-morpholinyl)ethyl]-, hydrochloride (1:1) | [CAS]
1275582-98-3 | [Synonyms]
Ibezapolstat hydrochloride
Ibezapolstat hydrochloride, 10 mM in DMSO
6H-Purin-6-one, 2-[[(3,4-dichlorophenyl)methyl]amino]-1,7-dihydro-7-[2-(4-morpholinyl)ethyl]-, hydrochloride (1:1) | [Molecular Formula]
C18H21Cl3N6O2 | [MOL File]
1275582-98-3.mol | [Molecular Weight]
459.76 |
| Hazard Information | Back Directory | [Uses]
Ibezapolstat hydrochloride is a first-in-class, orally active DNA polymerase IIIC (pol IIIC) inhibitor, with a Ki of 0.325 μM for the DNA pol IIIC from C. difficile. Ibezapolstat hydrochloride is developed for the research of C. difficile infection(CDI)[1][2]. | [References]
[1] Beverly Murray, et al. In vitro activity of the novel antibacterial agent ibezapolstat (ACX-362E) against Clostridioides difficile. J Antimicrob Chemother. 2020 Aug 1;75(8):2149-2155. DOI:10.1093/jac/dkaa134
[2] Andrea Torti, et al. Clostridium difficile DNA polymerase IIIC: basis for activity of antibacterial compounds. Curr Enzym Inhib. 2011 Oct; 7(3): 147-153. DOI:10.2174/157340811798807597
[3] Sofya Dvoskin, et al. A Novel Agent Effective against Clostridium difficile Infection. Antimicrob Agents Chemother. 2012 Mar; 56(3): 1624-1626. DOI:10.1128/AAC.06097-11 |
|
|